NCT01692405

Brief Summary

Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of:

  1. 1.Biopsy core length obtained (i.e. collecting all tissue fragments)
  2. 2.Biopsy core yield (i.e. percent of tissue loss during the pathologic processing)
  3. 3.Pathologist interpretability
  4. 4.Processing time
  5. 5.Prostate cancer detection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
436

participants targeted

Target at P75+ for not_applicable prostate-cancer

Timeline
Completed

Started Apr 2013

Typical duration for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 25, 2012

Completed
7 months until next milestone

Study Start

First participant enrolled

April 29, 2013

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2017

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2017

Completed
Last Updated

April 19, 2019

Status Verified

September 1, 2012

Enrollment Period

3.9 years

First QC Date

September 12, 2012

Last Update Submit

April 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • percent of tissue loss

    percent of biopsy tissue loss during pathologic processing. comparing the core length as recorded on the biopsy needle notch and on the histology slide

    1 year

Secondary Outcomes (2)

  • prostate cancer detection rate

    1 year

  • processing time

    1 year

Study Arms (3)

Standard method

NO INTERVENTION

Standard method- shaking the biopsy needle into a formalin container.

Download onto a biopsy sponge pad

ACTIVE COMPARATOR

Samples will be downloaded by moving the needle notch on a biopsy sponge pad.

Procedure: biopsy sponge pad

Dowloading the biopsy cores using NavigoBx system

EXPERIMENTAL

Downloading the biopsy cores using NavigoBx™ system. The NaviGoBx™ device is intended for the retention of a biopsy specimen and for preservation of the specimen's in-needle location and orientation.

Device: NaviGo Bx™

Interventions

The NaviGoBx™ system is a device and method that enables an accurate reporting of the exact longitudinal location and direction of the biopsy specimen along the needle notch as well as the accurate length of the specimen. Acquiring this information during the biopsy extraction session provides an accurate designation of the location of any later region of interest within the specimen itself to the longitudinal position along the needle mandrel.

Dowloading the biopsy cores using NavigoBx system

the biopsy core is downloaded onto a biopsy sponge pad which is than entered into a biopsy cassette.

Download onto a biopsy sponge pad

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Planned for radical or open prostatectomy operation or Planned for TRUS prostate biopsy procedure.
  • Signed informed consent.

You may not qualify if:

  • Patient's unwilling to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haemek madical center

Afula, 18101, Israel

Location

Related Publications (1)

  • Obek C, Doganca T, Erdal S, Erdogan S, Durak H. Core length in prostate biopsy: size matters. J Urol. 2012 Jun;187(6):2051-5. doi: 10.1016/j.juro.2012.01.075. Epub 2012 Apr 11.

    PMID: 22498214BACKGROUND

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2012

First Posted

September 25, 2012

Study Start

April 29, 2013

Primary Completion

April 5, 2017

Study Completion

April 24, 2017

Last Updated

April 19, 2019

Record last verified: 2012-09

Locations